Bactericidal eradication from carious lesions of prepared abutments by an antibacterial temporary cement.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 9104709)

Published in J Prosthet Dent on April 01, 1997

Authors

R Hori1, S Kohno, E Hoshino

Author Affiliations

1: Department of Removable Prosthodontics, Niigata University School of Dentistry, Japan.

Articles by these authors

(truncated to the top 100)

Endoscopic submucosal dissection for early gastric cancer: a large-scale feasibility study. Gut (2008) 4.07

Relationship between rifampin MICs for and rpoB mutations of Mycobacterium tuberculosis strains isolated in Japan. Antimicrob Agents Chemother (1996) 3.82

Plasma (1-->3)-beta-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet (1995) 3.64

Rapid detection and evaluation of clinical characteristics of emerging multiple-drug-resistant gram-negative rods carrying the metallo-beta-lactamase gene blaIMP. Antimicrob Agents Chemother (1998) 3.57

Relationship between antimycobacterial activities of rifampicin, rifabutin and KRM-1648 and rpoB mutations of Mycobacterium tuberculosis. J Antimicrob Chemother (1998) 3.41

International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections. Clin Infect Dis (1997) 2.78

Nested polymerase chain reaction for detection of Mycobacterium tuberculosis in clinical samples. J Clin Microbiol (1993) 2.27

Fulminating lactose-positive Vibrio septicemia. Acta Pathol Jpn (1978) 2.20

Investigation of the mechanism of alcohol-induced bronchial asthma. J Allergy Clin Immunol (1996) 2.16

Abscopal regression of hepatocellular carcinoma after radiotherapy for bone metastasis. Gut (1998) 2.11

A mechanism of erythromycin treatment in patients with diffuse panbronchiolitis. Am Rev Respir Dis (1993) 1.91

Sterilization of infected root-canal dentine by topical application of a mixture of ciprofloxacin, metronidazole and minocycline in situ. Int Endod J (1996) 1.86

Clinical evaluation of 61 patients with pulmonary aspergilloma. Intern Med (2000) 1.82

Predominant obligate anaerobes in human carious dentin. J Dent Res (1985) 1.73

Penetration of macrolides into human polymorphonuclear leucocytes. J Antimicrob Chemother (1989) 1.71

Plasma (1-->3)-beta-D-glucan and fungal antigenemia in patients with candidemia, aspergillosis, and cryptococcosis. J Clin Microbiol (1995) 1.63

Short report: possible Cryptosporidium muris infection in humans. Am J Trop Med Hyg (2000) 1.59

Role of coagulase in a murine model of hematogenous pulmonary infection induced by intravenous injection of Staphylococcus aureus enmeshed in agar beads. Infect Immun (1997) 1.57

Complications after cyst excision with hepaticoenterostomy for choledochal cysts and their surgical management in children versus adults. J Pediatr Surg (1997) 1.56

Rhodamine 6G efflux for the detection of CDR1-overexpressing azole-resistant Candida albicans strains. J Antimicrob Chemother (1999) 1.54

The antimicrobial activity of ciprofloxacin against Legionella species and the treatment of experimental Legionella pneumonia in guinea pigs. J Antimicrob Chemother (1986) 1.51

Clinicopathological factors associated with clinical outcomes of endoscopic submucosal dissection for colorectal epithelial neoplasms. Endoscopy (2009) 1.51

Hepatic artery pseudoaneurysms in a patient treated for miliary tuberculosis. Intern Med (2000) 1.48

Rapid prediction of rifampin susceptibility of Mycobacterium tuberculosis. Am J Respir Crit Care Med (1997) 1.47

Pranlukast, a cysteinyl leukotriene receptor 1 antagonist, attenuates allergen-specific tumour necrosis factor alpha production and nuclear factor kappa B nuclear translocation in peripheral blood monocytes from atopic asthmatics. Clin Exp Allergy (2003) 1.44

Re-analysis of clinical features of 89 patients with autoimmune hepatitis using the revised scoring system proposed by the International Autoimmune Hepatitis Group. Intern Med (2000) 1.43

Pulmonary mycobacteriosis caused by rifampicin-resistant Mycobacterium szulgai. Intern Med (2000) 1.43

Low prevalence of Helicobacter pylori in individuals with HTLV-I infection. Eur J Gastroenterol Hepatol (1999) 1.43

Long-term outcomes of endoscopic submucosal dissection for undifferentiated-type early gastric cancer. Endoscopy (2012) 1.41

Autoimmune reactivity of sera to hepatocyte plasma membrane in type 1 autoimmune hepatitis. J Gastroenterol (2000) 1.41

Breast cancer resistance protein directly confers SN-38 resistance of lung cancer cells. Biochem Biophys Res Commun (2001) 1.39

Sludge and stone formation in the gallbladder in bedridden elderly patients with cerebrovascular disease: influence of feeding method. J Gastroenterol (2001) 1.38

Spontaneous perforation of choledochal cyst: a study of 13 cases. Eur J Pediatr Surg (1998) 1.37

Immunokinetics in severe pneumonia due to influenza virus and bacteria coinfection in mice. Eur Respir J (2004) 1.37

Changes in titers of antimitochondrial and antinuclear antibodies during the course of primary biliary cirrhosis. J Gastroenterol Hepatol (2001) 1.37

Interleukin 1 beta, tumor necrosis factor alpha, and interleukin 8 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis: a potential mechanism of macrolide therapy. Respiration (1996) 1.37

Random amplified polymorphic DNA analysis of clinically and environmentally isolated Cryptococcus neoformans in Nagasaki. J Clin Microbiol (1995) 1.36

Predominant obligate anaerobes invading the deep layers of root canal dentin. Int Endod J (1990) 1.35

Synergic effects of tactolimus and azole antifungal agents against azole-resistant Candida albican strains. J Antimicrob Chemother (1998) 1.32

Comparison between PCR and detection of antigen in sera for diagnosis of pulmonary aspergillosis. J Clin Microbiol (1999) 1.27

Expression of endothelial and inducible nitric oxide synthase in human glomerulonephritis. Kidney Int (1998) 1.26

Implication of NF-kappaB in Helicobacter pylori-associated gastritis. Am J Gastroenterol (2000) 1.25

Long term effect of erythromycin therapy in patients with chronic Pseudomonas aeruginosa infection. Thorax (1995) 1.24

Enolase antigen, mannan antigen, Cand-Tec antigen, and beta-glucan in patients with candidemia. J Clin Microbiol (1996) 1.23

Pirfenidone attenuates expression of HSP47 in murine bleomycin-induced pulmonary fibrosis. Eur Respir J (2004) 1.23

Efficacy of FK463, a (1,3)-beta-D-glucan synthase inhibitor, in disseminated azole-resistant candida albicans infection in mice. Antimicrob Agents Chemother (2000) 1.23

Penetration of clinical isolates of Pseudomonas aeruginosa through MDCK epithelial cell monolayers. J Infect Dis (2000) 1.22

Particulate and soluble antigens of Rickettsia tsutsugamushi in the complement fixation test. J Immunol (1969) 1.21

Hepaticoenterostomy after excision of choledochal cyst in children: a 30-year experience with 180 cases. J Pediatr Surg (1996) 1.20

Overexpression of glutathione S-transferase pi enhances the adduct formation of cisplatin with glutathione in human cancer cells. Free Radic Res (1999) 1.20

Endodontic treatment of primary teeth using a combination of antibacterial drugs. Int Endod J (2004) 1.17

Cutting edge: an inducible sialidase regulates the hyaluronic acid binding ability of CD44-bearing human monocytes. J Immunol (1999) 1.17

Raised plasma concentrations of alpha-defensins in patients with idiopathic pulmonary fibrosis. Thorax (2002) 1.16

Expression of human beta-defensin 2 (hBD-2) in Helicobacter pylori induced gastritis: antibacterial effect of hBD-2 against Helicobacter pylori. Gut (2001) 1.16

Estimation of the gene frequency of aceruloplasminemia in Japan. Neurology (1999) 1.16

T cell-dependent activation of macrophages and enhancement of their phagocytic activity in the lungs of mice inoculated with heat-killed Cryptococcus neoformans: involvement of IFN-gamma and its protective effect against cryptococcal infection. Microbiol Immunol (1995) 1.16

Immunopathology of murine experimental allergic orchitis. J Immunol (1983) 1.15

A solitary bronchial papilloma with malignant changes. Intern Med (2001) 1.15

Antimicrobial activity of superoxidized water. J Hosp Infect (1996) 1.15

Direct interaction between a quinoline derivative, MS-209, and multidrug resistance protein (MRP) in human gastric cancer cells. Biochem Biophys Res Commun (1999) 1.15

A close relationship between Helicobacter pylori infection and gastric xanthoma. Scand J Gastroenterol (1999) 1.15

Application of ubiquinone systems and electrophoretic comparison of enzymes to identification of clinical isolates of Aspergillus fumigatus and several other species of Aspergillus. J Clin Microbiol (1992) 1.14

A 77-kilodalton protein of Cryptococcus neoformans, a member of the heat shock protein 70 family, is a major antigen detected in the sera of mice with pulmonary cryptococcosis. Infect Immun (1997) 1.14

Long-term efficacy and safety of clarithromycin treatment in patients with diffuse panbronchiolitis. Respir Med (2003) 1.13

Cryptosporidiosis in Indonesia: a hospital-based study and a community-based survey. Am J Trop Med Hyg (1998) 1.12

Elevation of tumor-associated carbohydrate antigens in patients with diffuse panbronchiolitis. Am Rev Respir Dis (1993) 1.12

Antitumor activity of phenylahistin in vitro and in vivo. Biosci Biotechnol Biochem (1999) 1.11

Evaluation of susceptibility of gram-positive and -negative bacteria to human defensins by using radial diffusion assay. Antimicrob Agents Chemother (1996) 1.11

Detection of Cryptococcus neoformans gene in patients with pulmonary cryptococcosis. J Clin Microbiol (1996) 1.11

High plasma concentrations of osteopontin in patients with interstitial pneumonia. Respir Med (2005) 1.10

Restriction fragment-length polymorphism analysis of 16S rDNA from oral asaccharolytic Eubacterium species amplified by polymerase chain reaction. Oral Microbiol Immunol (1998) 1.10

Adherence to and penetration of human intestinal Caco-2 epithelial cell monolayers by Pseudomonas aeruginosa. Infect Immun (1998) 1.09

Effects of antifungal agent combinations administered simultaneously and sequentially against Aspergillus fumigatus. Antimicrob Agents Chemother (1994) 1.09

A rare case of eosinophilic pleuritis due to sparganosis. Intern Med (2001) 1.09

Fluconazole monotherapy for cryptococcosis in non-AIDS patients. Eur J Clin Microbiol Infect Dis (1996) 1.08

Detection of (1-3)-beta-D-glucan in a rat model of aspergillosis. J Clin Lab Anal (1995) 1.08

Preferential induction of rough variants in Streptococcus mutans by ethidium bromide. J Dent Res (1973) 1.07

Cryptobacterium curtum gen. nov., sp. nov., a new genus of gram-positive anaerobic rod isolated from human oral cavities. Int J Syst Bacteriol (1999) 1.07

Increase in activated CD8+ cells in bronchoalveolar lavage fluid in patients with diffuse panbronchiolitis. Am J Respir Crit Care Med (1995) 1.06

Asymptomatic cap polyposis from the sigmoid colon to the cecum. Gastrointest Endosc (2001) 1.06

Evaluation of plasma (1-->3)-beta-D-glucan measurement by the kinetic turbidimetric Limulus test, for the clinical diagnosis of mycotic infections. Eur J Clin Chem Clin Biochem (1997) 1.05

In vitro antimicrobial susceptibility to combinations of drugs on bacteria from carious and endodontic lesions of human deciduous teeth. Oral Microbiol Immunol (1993) 1.05

Studies on interferon priming: cellular response to viral and nonviral inducers and requirement of protein synthesis. Virology (1981) 1.05

Detection of Candida enolase antibody in patients with candidiasis. J Clin Lab Anal (1994) 1.05

Elevated concentrations of defensins in bronchoalveolar lavage fluid in diffuse panbronchiolitis. Eur Respir J (1998) 1.05

Identification and characterization of "injurin," an inducer of expression of the gene for hepatocyte growth factor. Proc Natl Acad Sci U S A (1992) 1.04

Small bowel pseudo-obstruction in Kawasaki disease. Pediatr Radiol (1987) 1.04

Treponema medium sp. nov., isolated from human subgingival dental plaque. Int J Syst Bacteriol (1997) 1.03

Proximal extension of cap polyposis confirmed by colonoscopy. Gastrointest Endosc (2001) 1.03

Erythromycin inhibits neutrophil chemotaxis in bronchoalveoli of diffuse panbronchiolitis. Chest (1994) 1.03

Predominant obligate anaerobes in human periodontal pockets. J Periodontal Res (1992) 1.03

High serum concentrations of surfactant protein A in usual interstitial pneumonia compared with non-specific interstitial pneumonia. Thorax (2003) 1.03

Transport of 7-ethyl-10-hydroxycamptothecin (SN-38) by breast cancer resistance protein ABCG2 in human lung cancer cells. Biochem Biophys Res Commun (2001) 1.03

Expression of human T lymphotropic virus type 1 (HTLV-1) tax/rex gene in fresh bronchoalveolar lavage cells of HTLV-1-infected individuals. Clin Exp Immunol (1994) 1.03

Acute infection with influenza virus enhances susceptibility to fatal pneumonia following Streptococcus pneumoniae infection in mice with chronic pulmonary colonization with Pseudomonas aeruginosa. Clin Exp Immunol (2004) 1.02

Detection of Bacteroides fragilis in clinical specimens by PCR. J Clin Microbiol (1994) 1.02

Rapid and highly reproducible method for antifungal susceptibility testing of Aspergillus species. J Clin Microbiol (1993) 1.02

Differing effects of clarithromycin and azithromycin on cytokine production by murine dendritic cells. Clin Exp Immunol (2007) 1.02

Description of Mogibacterium pumilum gen. nov., sp. nov. and Mogibacterium vescum gen. nov., sp. nov., and reclassification of Eubacterium timidum (Holdeman et al. 1980) as Mogibacterium timidum gen. nov., comb. nov. Int J Syst Evol Microbiol (2000) 1.01

In-vitro and in-vivo activities of SCH56592 against Cryptococcus neoformans. J Antimicrob Chemother (1999) 1.01